These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1799355)

  • 61. The efficacy of Femal in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study.
    Gerhardsen G; Hansen AV; Killi M; Fornitz GG; Pedersen F; Roos SB
    Adv Ther; 2008 Jun; 25(6):595-607. PubMed ID: 18568441
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Spironolactone for the treatment of PMS.
    Hendler N
    Md Med J; 1992 Apr; 41(4):286. PubMed ID: 1569834
    [No Abstract]   [Full Text] [Related]  

  • 63. Premenstrual tension and functional infertility. Aetiology and treatment.
    Benedek-Jaszmann LJ; Hearn-Sturtevant MD
    Lancet; 1976 May; 1(7969):1095-8. PubMed ID: 57506
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bulimia, menstruation, and PMS: treatment implications.
    Price WA; DiMarzio LR
    Am J Psychiatry; 1988 Sep; 145(9):1178-9. PubMed ID: 3414867
    [No Abstract]   [Full Text] [Related]  

  • 65. A double-blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome.
    Maddocks S; Hahn P; Moller F; Reid RL
    Am J Obstet Gynecol; 1986 Mar; 154(3):573-81. PubMed ID: 3513587
    [TBL] [Abstract][Full Text] [Related]  

  • 66. No effect of vitamin B-6 against premenstrual tension. A controlled clinical study.
    Hagen I; Nesheim BI; Tuntland T
    Acta Obstet Gynecol Scand; 1985; 64(8):667-70. PubMed ID: 3914180
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Premenstrual syndrome. A general practice view.
    McMurchie M; Hindmarsh E
    Aust Fam Physician; 1989 Feb; 18(2):105, 108-9. PubMed ID: 2705942
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria.
    Steinberg S; Annable L; Young SN; Liyanage N
    Biol Psychiatry; 1999 Feb; 45(3):313-20. PubMed ID: 10023508
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Progesterone treatment of premenstrual tension--a double blind study.
    Andersch B; Hahn L
    J Psychosom Res; 1985; 29(5):489-93. PubMed ID: 3906106
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Melatonin and the reduction or alleviation of stress.
    Kirby AW; Clayton M; Rivera P; Comperatore CA
    J Pineal Res; 1999 Sep; 27(2):78-85. PubMed ID: 10496143
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fluctuations in symptoms and moods during the menstrual cycle.
    Moos RH; Kopell BS; Melges FT; Yalom ID; Lunde DT; Clayton RB; Hamburg DA
    J Psychosom Res; 1969 Mar; 13(1):37-44. PubMed ID: 5813369
    [No Abstract]   [Full Text] [Related]  

  • 72. Puerperal and premenopausal depression.
    Med J Aust; 1972 Mar; 1(11):504. PubMed ID: 5066529
    [No Abstract]   [Full Text] [Related]  

  • 73. Spironolactone treatment in scleroderma--a double-blind therapy study.
    Altmeyer P; Goerz G; Hammer H; Holzmann H; Krieg T; Luderschmidt C; Meigel WN; Mensing H
    Dermatologica; 1985; 171(5):374-5. PubMed ID: 3908176
    [No Abstract]   [Full Text] [Related]  

  • 74. Determination of premenstrual symptom exacerbations.
    Harvey A; Kornstein SG
    Am J Psychiatry; 2011 Sep; 168(9):989; author reply 989-90. PubMed ID: 21890807
    [No Abstract]   [Full Text] [Related]  

  • 75. Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study.
    Wang M; Hammarbäck S; Lindhe BA; Bäckström T
    Acta Obstet Gynecol Scand; 1995 Nov; 74(10):803-8. PubMed ID: 8533564
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sex differences in the hypothalamic-pituitary-adrenal axis: An obstacle to antidepressant drug development?
    Kokras N; Hodes GE; Bangasser DA; Dalla C
    Br J Pharmacol; 2019 Nov; 176(21):4090-4106. PubMed ID: 31093959
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder?
    Halbreich U; O'Brien PM; Eriksson E; Bäckström T; Yonkers KA; Freeman EW
    CNS Drugs; 2006; 20(7):523-47. PubMed ID: 16800714
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The role of hormones and hormonal treatments in premenstrual syndrome.
    Bäckström T; Andreen L; Birzniece V; Björn I; Johansson IM; Nordenstam-Haghjo M; Nyberg S; Sundström-Poromaa I; Wahlström G; Wang M; Zhu D
    CNS Drugs; 2003; 17(5):325-42. PubMed ID: 12665391
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Premenstrual syndrome and spironolactone.
    Burnet RB; Radden HS; Easterbrook EG; McKinnon RA
    Aust N Z J Obstet Gynaecol; 1991 Nov; 31(4):366-8. PubMed ID: 1799355
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A double-blind, placebo-controlled evaluation of spironolactone in the premenstrual syndrome.
    Vellacott ID; Shroff NE; Pearce MY; Stratford ME; Akbar FA
    Curr Med Res Opin; 1987; 10(7):450-6. PubMed ID: 3621990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.